24 HR empagliflozin 25 MG / linagliptin 5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet
RxNorm concept 2359351, clinical drug (scd). Prescribable name: empagliflozin 25 MG / linagliptin 5 MG / metFORMIN hydrochloride 1000 MG 24HR Extended Release Oral Tablet.
- RxCUI
- 2359351
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2359351 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
24 HR empagliflozin 25 MG / linagliptin 5 MG / metFORMIN hydrochloride 1000 MG Extended Release Oral Tablet
Related concepts
- metformin hydrochloride 1000 MG (SCDC, consists of)
- linagliptin 5 MG (SCDC, consists of)
- empagliflozin 25 MG (SCDC, consists of)
- Extended Release Oral Tablet (DF, has dose form)
- 24 HR empagliflozin 25 MG / linagliptin 5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Trijardy] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2359351 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2359351 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2359351. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.